These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6499362)

  • 1. Prednisolone disposition in obese men.
    Milsap RL; Plaisance KI; Jusko WJ
    Clin Pharmacol Ther; 1984 Dec; 36(6):824-31. PubMed ID: 6499362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline disposition in obesity.
    Gal P; Jusko WJ; Yurchak AM; Franklin BA
    Clin Pharmacol Ther; 1978 Apr; 23(4):438-44. PubMed ID: 630791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procainamide disposition in obesity.
    Christoff PB; Conti DR; Naylor C; Jusko WJ
    Drug Intell Clin Pharm; 1983; 17(7-8):516-22. PubMed ID: 6191939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
    Meffin PJ; Wing LM; Sallustio BC; Brooks PM
    Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, sex, and acetaminophen disposition.
    Abernethy DR; Divoll M; Greenblatt DJ; Ameer B
    Clin Pharmacol Ther; 1982 Jun; 31(6):783-90. PubMed ID: 7075126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and exogenous glucocorticoids in cushingoid patients.
    Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
    Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
    Nichols AI; D'Ambrosio R; Pyszczynski NA; Jusko WJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):963-70. PubMed ID: 2778721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone disposition and protein binding in oral contraceptive users.
    Boekenoogen SJ; Szefler SJ; Jusko WJ
    J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
    Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
    Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.
    Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):453-67. PubMed ID: 3806371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF; Benet LZ
    Clin Pharmacol Ther; 1986 Apr; 39(4):425-9. PubMed ID: 3956058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline disposition in obese rats.
    Shum L; Jusko WJ
    J Pharmacol Exp Ther; 1984 Feb; 228(2):380-6. PubMed ID: 6694116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisolone disposition in steroid-dependent asthmatics.
    Rose JQ; Nickelsen JA; Middleton E; Yurchak AM; Park BH; Jusko WJ
    J Allergy Clin Immunol; 1980 Nov; 66(5):366-73. PubMed ID: 7440853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
    Rose JQ; Yurchak AM; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine disposition in obesity.
    Abernethy DR; Todd EL; Schwartz JB
    Br J Clin Pharmacol; 1985 Jul; 20(1):61-6. PubMed ID: 4027137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent protein binding and disposition of prednisolone in rabbits.
    Rocci ML; Jusko WJ
    J Pharm Sci; 1981 Nov; 70(11):1201-4. PubMed ID: 7299663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol does not inhibit prednisolone clearance.
    Meffin PJ; Sallustio BC; Purdie YJ; Robson RA; Wing LM; Brooks PM
    Br J Clin Pharmacol; 1985 Oct; 20(4):414-6. PubMed ID: 4074609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.